MedPath

Mobile Health Intervention to Support Healthful Diet

Not Applicable
Completed
Conditions
Frailty
Interventions
Behavioral: Mobile app
Registration Number
NCT05236712
Lead Sponsor
University of Washington
Brief Summary

This will be a pilot clinical trial to evaluate preliminary efficacy of a newly designed mobile intervention designed to support healthy eating in old people. The main scientific premise of this project is that mobile approaches are feasible for behavioral and metabolic improvements in the population of people 65+ with mild-to-moderate frailty. Specific Aim of this project is to describe feasibility, acceptability and initial efficacy of the newly designed mobile intervention in a pilot RCT. The pilot RCT, comparing usual care to usual care plus mobile intervention, will provide data on the sensitivity of outcome measures and estimated effect size to inform a larger RCT. Primary outcomes for the pilot RCT will include change in adherence to Mediterranean diet (MedD) score, change in insulin sensitivity measures, feasibility and acceptability. Secondary outcomes include MedD knowledge, self-efficacy, outcome expectation, self-regulation, social support, platform use and anthropometric and functional measures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria

Age 65+

Mild to moderate frailty

Suboptimal diet

Read More
Exclusion Criteria
  1. Dependence in activities of daily living
  2. Memory Impairment
  3. Hearing or visual impairment
  4. Unusual dietary restrictions
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mobile healthMobile appParticipants will receive access to a mobile app installed on their device and will be asked to use the app at least once a week
Primary Outcome Measures
NameTimeMethod
Change From Baseline HOMA-IR Score at 3 Monthsbaseline, 3 month

Insulin resistance scores, homeostatic model (HOMA-IR) was calculated with the following formula: fasting plasma glucose (in mmol/L) X fasting plasma insulin (in lU/mL) divided by 22.5. Higher score indicates worse insulin resistance. Typically, a HOMA-IR value of less than 1 is considered normal, indicating low insulin resistance.

Change From Baseline Mediterranean Diet (MED) Adherence Score at 3 Monthsbaseline, 3 month

Alternative MED (aMED) score will be calculated using the Food Frequency Questionnaire (FFQ). aMED scores range from 0 (nonadherence) to 9 (perfect adherence)

Secondary Outcome Measures
NameTimeMethod
Change From Baseline Negative Outcome Expectations Score at 3 Monthsbaseline, 3 month

Questionnaire, 6 items rated on a 5-point scale (strongly agree 5; strongly disagree 1). Higher score more negative outcome expectations. The total score ranges from 30 to 6

Change From Baseline Positive Outcome Expectations Score at 3 Monthsbaseline, 3 month

Questionnaire, 7 items rated on a 5-point scale (strongly agree 5; strongly disagree 1). Higher score more positive outcome expectations. The total scale ranges from 7 to 35

Change From Baseline Self-Efficacy Score at 3 Monthsbaseline, 3 month

Visual analog scale (VAS), 6 items using a 10-point scale. Higher values more self-efficacy. The total score ranges from O to 60

Change From Baseline Social Support Score at 3 Monthsbaseline, 3 month

Questionnaire, 2 items rated on a 5-point scale (strongly agree 5; strongly disagree 1). Higher score more social support. The total score ranges from 10 to 2

Change From Baseline Mediterranean Diet Knowledge Score at 3 Monthsbaseline, 3 month

MedD knowledge will be assessed using the Mediterranean Diet Nutrition Knowledge (MDNK) Questionnaire. The total scores range from 0 to 30. Higher score higher knowledge

Change From Baseline Physical Performance Measure at 3 Monthsbaseline, 3 month

Short Physical Performance Battery (SPPB) is a composite measure assessing walking speed, standing balance, and sit-to-stand performance. The three tests are summed to give a total score, with a maximum of 12 and minimum of 0. Higher score higher function

Change From Baseline BMI at 3 Monthsbaseline, 3 month

BMI in units

Change From Baseline Self-regulation Score at 3 Monthsbaseline, 3 month

Questionnaire, 2 items rated on a 5-point scale (strongly agree 5; strongly disagree 1). Higher score more self-regulation. The total scale ranges from 10 to 2

Trial Locations

Locations (1)

Univeristy of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath